Effects of Schizophrenia and Bipolar Disorder on Exercise Capacity, Pulmonary Function, and Quality of Life

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-65
SponsorÇankırı Karatekin University

About this trial

This observational study aims to evaluate exercise capacity, pulmonary function, respiratory muscle strength, and quality of life in individuals diagnosed with schizophrenia and bipolar disorder. These psychiatric conditions are associated with sedentary lifestyles, metabolic side effects of psychotropic medications, and increased comorbidity risks, all of which may negatively impact physical fitness and respiratory health. By assessing cardiorespiratory endurance, pulmonary parameters (FVC, FEV₁), and respiratory muscle strength in this population, the study seeks to identify physiological limitations and contribute to the development of more effective rehabilitation strategies. The findings may support multidisciplinary approaches to improving physical health and overall quality of life in individuals with severe mental illness.

Eligibility criteria

Qualifiers

Being volunteer for participation

Being 18 to 65 age

Disqualifiers

Having any respiratory, cardiac, neurologic or orthopedic disease which may affect respiratory functions or exercise capacity

Having any neuropsychiatric disease except schizophrenia or bipolar disorder

Trial design

Treatments tested in this trial

  • Pulmonary Function Test
  • Respiratory Muscle Strength Evaluation
  • Quality of Life Assessment
  • Exercise Capacity Assessment

Treatment groups

150 Participants
are divided into 3 treatment groups